-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
MEI Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2024.
- MEI Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.35M, a 115% decline year-over-year.
- MEI Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$49.1M, a 234% decline year-over-year.
- MEI Pharma, Inc. annual Operating Income (Loss) for 2024 was $14.5M.
- MEI Pharma, Inc. annual Operating Income (Loss) for 2023 was -$36.8M, a 51.3% increase from 2022.
- MEI Pharma, Inc. annual Operating Income (Loss) for 2022 was -$75.5M, a 24.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)